Research guide · Source evidence and limits
Researching Irish pharmaceutical manufacturing accounts
For an industrial supplier, a useful pharmaceutical account is more than a company name beside a medicine. The research needs to connect a particular organisation, an Irish operating location and an evidenced activity to the supplier's brief. Product, company and facility records answer different questions.
This guide helps you make that connection without turning a regulatory record into an equipment lead. Its practical output is a short facility-fit note and an acceptance checklist. It is not a directory of available work, a compliance assessment or regulatory advice. The territory here is the Republic of Ireland; state explicitly if your own brief also includes Northern Ireland.
Begin with the decision your supplier brief needs
Write down the activity or customer role that could make an account relevant to your range. Then ask which public evidence would support that connection. These are original research questions, not official classifications:
- Are you looking for an operating facility, an engineering-service business, or both?
- Is the source describing the work performed at a particular location or the corporate group more generally?
- Does that description answer the question in your brief, or merely contain the word “pharmaceutical”?
- Which missing fact would change an include, hold or exclude decision?
For a fictional packaging-service brief, a source describing packaging work could justify further research into that activity. The same observation does not answer a different supplier's question about process-production operations. Treat the distinction as a limit on the evidence—not as a conclusion about equipment needs or the site's commercial value.
A medicine approval is not a facility description
EMA defines marketing authorisation as approval to market a medicine in one, several or all EU Member States.[5] That is a product-market concept. For an industrial account brief, keep it separate from evidence identifying an operating site and its activity.
An address attached to a product or its associated organisation does not, on its own, answer your manufacturing-location question. Seek separate, site-specific evidence. Record the exact entity and location named by each source rather than transferring a group-level statement to every site.
Use the existing company and facility mapping guide for the mechanics of linking those records. This pharmaceutical guide adds a record-type check; it does not replace that identity workbook.
Record what kind of evidence you actually found
EMA describes EudraGMDP as a database covering manufacturing, import and wholesale-distribution authorisations, alongside good-manufacturing-practice and good-distribution-practice certificates.[4] Do not flatten those different record categories into one generic “production plant” label.
For each relevant record, capture its type, the organisation and site it identifies, the activity or scope actually stated, its document date where available, and your retrieval date. Compare those observations with an appropriate current first-party description of the facility. A conflict is a reason to hold the affected conclusion, not silently choose the version that makes the account look stronger.
This guide does not reproduce database entries or establish any facility's current status. Use the source to investigate a defined question, not to infer current equipment, supplier-selection authority or a purchasing decision. An unsuccessful search also does not establish that an organisation is unauthorised or absent.
A useful research conclusion is bounded: “the reviewed source describes this activity at this location; the connection to our supplier brief still needs this check.” It is not “this facility needs our product”. For service businesses, the relevant evidence may describe the service they perform rather than an operating facility—keep that route separate.
Keep engineering-service relevance on a separate route
For an operator account, seek evidence of the relevant activity at the facility. For an engineering or maintenance business, seek evidence of the service it performs and the customer role your brief requires. Do not reject a service business merely because it is not the medicine manufacturer; do not count it as a manufacturing facility either.
A contractor's pharmaceutical case study can establish only what it actually describes. Check whether it concerns design, installation, commissioning, maintenance or another service, and whether the work is historical. Do not infer an ongoing appointment, supplier-selection authority or a current purchasing package from the customer's name or logo.
Likewise, an operator can be a relevant end-user account while another organisation selects or orders a component. Preserve “operator”, “specifier”, “installer” and “purchaser” as questions to resolve, not roles automatically assigned to the best-known brand. The pump and flow-control prospecting guide develops that customer-route distinction.
A facility-fit note you can copy
Use this short note inside your existing research worksheet. It is an original decision aid, not an official classification or a substitute for technical review.
Account and location: legal entity; group if relevant; operating facility and territory. Keep the registered or marketing address separate where it is not the evidenced operating site.
Observed activity: a precise statement of the work the source describes. Identify whether the record concerns production, packaging, importation, testing or a service business; allow multiple activities when evidenced.
Evidence: source URL; document title or record reference; publication or document date where available; retrieval date; the narrow statement supported. Check source-use terms before putting source material into a customer deliverable.
Supplier-relevance question: explain the connection to your range without answering an engineering question you have not investigated. For an instrumentation service, for example: “Does the described facility activity fall within our agreed service brief?” Do not substitute “requires calibration” unless that requirement is actually established.
Customer route and gaps: record the organisation's evidenced role, then list unresolved operating status, application detail, technical requirements, service responsibility and purchasing route. Unknown is an acceptable research result.
Decision: include for further account research, hold for a named missing check, or exclude from this particular brief. Store any separately evidenced development independently of the account-fit decision.
Before accepting a pharmaceutical account list
- ☐ Each included record has an evidenced operating activity, not just a medicine, sector label or marketing address.
- ☐ The entity and relevant facility are distinguishable; several sites are not silently counted as several companies.
- ☐ Record type and stated activity have not been flattened into a generic production label.
- ☐ Packaging, importation, testing and engineering-service businesses are evaluated against the actual supplier brief.
- ☐ Service-provider evidence is not presented as proof of current appointment or purchasing authority.
- ☐ The inclusion reason identifies a research connection to the offer without claiming technical suitability.
- ☐ Conflicts, source dates and missing checks remain visible.
- ☐ Account fit and any development signal are recorded separately; neither is labelled buying intent.
Turn the shortlist into a useful research brief
You do not need a new project announcement to investigate an industry-matched account. Begin with the facility activity, territory, customer role and exclusions that matter to your business. Add a development-signal question only where it serves a separate, defined purpose.
Compare the fictional account-research sample with the note above. If you need analyst-supported work, review industrial account research and request a written scope. Describe your range and the kinds of facilities or service businesses you need to understand; keep confidential customer records and personal contact data out of the enquiry.
Evidence, attribution and limits
EMA guidance and its source-use notice were checked on 5 October 2026. The brief descriptions of marketing authorisation and EudraGMDP above are attributed to the European Medicines Agency, © EMA 1995–2026.[4][5] EMA's website notice permits commercial reproduction with source acknowledgement, subject to its stated exceptions; no third-party document, database entry, photograph or logo is reproduced here.[6]
The supplier-selection questions, fictional example, facility-fit note and checklist are DemandRange's original analysis. They are not official EMA classifications. EMA does not endorse DemandRange or this guide. No individual facility's current authorisation, equipment requirements or purchasing plans were assessed; nothing here confers regulatory approval, engineering assurance or rights to reuse another source in a customer deliverable.